CADENCE PHARMACEUTICALS, INC.

Inactive Instrument

Cadence Pharmaceuticals, Inc. Stock

Stocks

US12738T1007

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

14-05-06

Actavis : Factbox - M&A frenzy transforming global pharma

RE

on all subscriptions*

Exceptional extension!

Enjoy this offer

* See conditions under "Our services"

Latest news : Cadence Pharmaceuticals, Inc.

14-05-06

Actavis : Factbox - M&A frenzy transforming global pharma

RE

Press Releases: Cadence Pharmaceuticals, Inc.

14-02-28	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	PR
14-02-17	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc	BU
14-02-14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.	BU
14-02-13	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc -- CADX	BU
14-02-13	Cadence Pharmaceuticals, Inc. : CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Proposed Sale of the Company to Mallinckrodt plc	BU

More press releases

Managers and Directors: Cadence Pharmaceuticals, Inc.

Manager	Title	Age	Since
Bryan Reasons PSD	President	58	-
Diane K. Sheehan HRO	Human Resources Officer	56	2006-04-30

Director	Title	Age	Since
Marvin R. Haselhorst BRD	Director/Board Member	-	2014-03-18
Bryan Reasons BRD	Director/Board Member	58	-

Biopharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	REGENERON PHARMACEUTICALS, INC.	+0.90%	+0.50%	+21.25%	-20.75%	62.32B
	UCB	+1.66%	-2.89%	+59.81%	+201.29%	53.94B
	SAMSUNG BIOLOGICS CO.,LTD.	-1.70%	+27.30%	+27.30%	+27.30%	38.98B
	CSL LIMITED	-0.74%	+6.17%	-53.36%	-60.27%	37.89B
	BIOGEN INC.	-1.26%	-0.73%	+55.22%	-32.92%	29.48B
	MODERNA, INC.	+2.79%	+17.02%	+135.52%	-49.37%	23.55B
	INCYTE CORPORATION	+0.71%	+2.37%	+52.50%	+68.63%	20.71B
	INNOVENT BIOLOGICS, INC.	+1.53%	-1.16%	-1.54%	+143.24%	16.71B
	SWEDISH ORPHAN BIOVITRUM AB	+4.86%	+7.22%	+71.09%	+121.25%	16.02B
	Average	+0.97%	+0.93%	+40.87%	+44.27%	33.29B
	Weighted average by Cap.	+0.66%	+0.08%	+35.42%	+39.95%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!